4//SEC Filing
Schwartz Jonathan David 4
Accession 0001140361-25-034420
CIK 0001281895other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:15 PM ET
Size
5.0 KB
Accession
0001140361-25-034420
Insider Transaction Report
Form 4
Schwartz Jonathan David
See Remarks
Transactions
- Award
Common Stock
2025-09-08+80,000→ 301,609 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001726398
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:15 PM ET
- Size
- 5.0 KB